Shares in this e-commerce company have languished since the pandemic's height. Will it ever recover to previous highs?

Medicare reimbursement issues expected for certain of Organogenesis' skin substitute projects disrupting revenues in 2025.

The ASX 200 benchmark hit another record high today, as the banks, InfoTech and Materials sectors put on some very tidy gains ...

"Markets have gradually picked up with Nifty sustaining above the 25k mark. We expect this up-move to continue in the market ...